Insider Transactions Reported by 18 Insiders of Indaptus Therapeutics, Inc.

Symbol
INDP on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 20 Jan 2025

Indaptus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Glen R. Anderson 10%+ Owner $2,785,536 10 Aug 2023
Hoonmo Lee Director $1,626,157 04 Aug 2021
Jeffrey Meckler Co-Chief Executive Officer, Director, 10%+ Owner $605,305 22 Dec 2025
Michael Newman CSO and Director, Director $205,180 22 Dec 2025
Walt Linscott Chief Operating Officer $110,484 22 Dec 2025
Nir Sassi Chief Financial Officer $54,318 22 Dec 2025
Roger J. Waltzman Chief Medical Officer $5,325 09 Oct 2024
Boyan Litchev Chief Medical Officer $2,691 01 Feb 2022
BRIAN O'CALLAGHAN Director $976 30 Sep 2022
Mark J. Gilbert Director $888 10 Jun 2025
Robert Martell Director $888 10 Jun 2025
Avraham Ben-Tzvi Director $223 22 Dec 2025
Roger Pomerantz Director $0 10 Jun 2025
Anthony Maddaluna Director $0 10 Jun 2025
Hila Karah Director $0 10 Jun 2025
William B. Hayes Director $0 10 Jun 2025
David Lazar Co-Chief Executive Officer $0 22 Dec 2025
David Natan Director 08 Jan 2026

Recent Insider Transactions by Companies or Individuals for Indaptus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.